Accuratasp. z o.o.

Accounting, bookkeeping and auditing activities; tax consultancy

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-01-28
Share capital
5,000.00 PLN
Registered address
ul. Kasztanowa 3, 16-010 Wasilków, Poland
Electronic delivery address
AE:PL-36781-24174-JUBAR-22

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$1,207

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 94 days for 2021).

  • 202515/07/2026
  • 202414/07/2025
  • 202316/04/2024
  • 202218/07/2023
  • 202117/10/2022
  • 202015/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

City · Wasilków35 / 50
Top 70%
Voivodeship · Podlaskie3,323 / 5,644
Top 59%
Country · Poland166,819 / 297,873
Top 56%

Results vs industry

Revenue
This companyUSD 194.56kMedianUSD 82.54kAverageUSD 480.31k
Net profit
This companyUSD 12.19kMedianUSD 6.27kAverageUSD 42.86k
Operating costs
This companyUSD 181.16kMedianUSD 69.72kAverageUSD 419.75k
Assets
This companyUSD 102.20kMedianUSD 46.59kAverageUSD 356.98k

Authorized Representatives

Dorota Snitkowska – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Dorota Snitkowskaage 45
50$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-03-03.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $2,391.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$371
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$373

Competitors

FAQ

Last updated: 2026-10-07